Professor, Medicine, University of California Los Angeles David Geffen SOM
Endocrinology
Dr. Jerome M. Hershman, MD
|
|
Give Review
Doctor Jerome M. Hershman, MD works in the field of Endocrinology. He graduated from University of Illinois College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Jerome M. Hershman, MD is a published MD. He published 38 publications, including: 'Lozenge-Induced Hypermineralcorticoid State--A Unique Case of Licorice Lozenges Resulting in Hypertension and Hypokalemia.' He accepts all Medicare patients.
Publications
- Thyrotoxicosis of Pregnancy.
- Sunitinib Does Not Block Thyroid Peroxidase in Patients.
- Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: Is There a Correlation?
- Medullary Thyroid cancer-current treatment strategy, novel therapies and perspectives for the future.
- In Memoriam Leonard D. Kohn, 1935-2012.
- Cooperative effects of SAHA and VPA on NIS gene expression and proliferation of Thyroid cancer cells.
- Tyrosine Kinase Inhibitors Noncompetitively Inhibit MCT8-Mediated Iodothyronine Transport.
- Prevention of DNA double-strand breaks induced by radioiodide-(131)I in FRTL-5 Thyroid cells.
- Update in Thyroidology 2010.
- Stability of recombinant human thyrotropin potency based on bioassay in FRTL-5 cells.
- Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary Thyroid cancer.
- How does sunitinib cause Hypothyroidism?
- Indomethacin inhibits cell growth of medullary Thyroid carcinoma by reducing cell cycle progression into S phase.
- The role of human chorionic gonadotropin as a Thyroid stimulator in normal pregnancy.
- Effect of sunitinib on growth and function of FRTL-5 Thyroid cells.
- Identification of cyclic adenosine 3',5'-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer.
- Expression of hepatocyte nuclear factor-1alpha mRNA in human anaplastic thyroid cancer cell lines and Tumors.
- Thyroid-stimulating hormone increases active transport of perchlorate into Thyroid cells.
- Cinacalcet for the treatment of primary Hyperparathyroidism.
- Sunitinib induces Hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity.
- RET/papillary Thyroid carcinoma oncogenic signaling through the Rap1 small GTPase.
- AntiTumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
- Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary Thyroid ca...
- Anaplastic thyroid carcinoma with thyrotoxicosis and Hypoparathyroidism.
- Perchlorate and Thyroid function: what are the environmental issues?
- Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary Thyroid cancer cells.
- Partial withdrawal of levothyroxine to stimulate serum thyroglobulin for Thyroid cancer monitoring.
- Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts Thyroid carcinoma cell response to retinoid and thiazolidinedione tr...
- Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in Thyroid carcinoma cells.
- Subclinical thyroid Disease: scientific review and guidelines for diagnosis and management.
- Enhanced expression of nicotinamide N-methyltransferase in human papillary Thyroid carcinoma cells.
- Bisphosphonate therapy in primary Hyperparathyroidism.
- Nonradioactive iodide effectively induces apoptosis in genetically modified lung Cancer cells.
- A Thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-lik...
- Lithium-associated Thyroiditis.
- A GC box in the human sodium iodide symporter gene promoter is essential for full activity.
- Lozenge-Induced Hypermineralcorticoid State--A Unique Case of Licorice Lozenges Resulting in Hypertension and Hypokalemia.
Schools
University Of Illinois College Of Medicine Chicago
Cook Co Hospital
Beth Israel Hospital
Boston Va Hospital
New Eng Center Hospital
Conditions Treated
- Diabetes Type 2
- Goiter
- Graves' Disease
- Hashimoto's Disease
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Tufts Medical Center -
John H. Stroger Hospital of Cook County -
University of Illinois College of Medicine
Hospital
-
Cedars-Sinai Medical Center -
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1326067273 | |
| NPPES Provider LastName | HERSHMAN | |
| NPPES Provider FirstName | JEROME | |
| NPPES Provider ZIPCode | 90095 | |
| NPPES Provider State | CA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 104.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326067273 |
| Last Name Of The Provider | HERSHMAN |
| First Name Of The Provider | JEROME |
| View All |
Similar Doctors
|
Dr. Jordan L. Geller, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald S. Levey, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mark L. Saginor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine H. Darwin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret L. England, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tisha Baird, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Helen L. Baron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Masahiro Sugawara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley H. Hsia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Michael J. Salzer |